首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >A Study of GWAS-Supported Variants of rs9943582 in a Chinese Han Population with Ischemic Stroke: No Associations with Disease Onset and Clinical Outcomes
【24h】

A Study of GWAS-Supported Variants of rs9943582 in a Chinese Han Population with Ischemic Stroke: No Associations with Disease Onset and Clinical Outcomes

机译:具有缺血性卒中的中国汉族人群Rs9943582的GWAS支持变种研究:没有疾病发病和临床结果的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Background The variant rs9943582 of APLNR (apelin receptor) was identified by a large-scale study to be associated with an increased risk of ischemic stroke in a Japanese population. We conducted this study to investigate the association between the variant and age of onset and clinical outcomes of ischemic stroke in a Chinese population. Methods Improved multiple ligase detection reaction was used to genotype the variant. We compared the mean age at ischemic stroke onset with one-way ANOVA. The Kaplan–Meier method, log-rank test, and Cox proportional hazards regression models were performed to analyze the association between the variant and clinical outcomes (recurrence and death). Results A total of 916 ischemic stroke patients were recruited for the study. For age at ischemic stroke onset, no significant association was identified with the variant in any genetic model. In addition, the variant was not strongly associated with recurrence and death risk of ischemic stroke, as shown by the results. Conclusions The findings indicated that the variant rs9943582 was not associated with age at onset and clinical outcomes of ischemic stroke. However, evidence from well-designed studies with larger and in different ethnic populations are warranted to further explore the effects of APLNR on the ischemic stroke onset and clinical outcomes. ]]>
机译:背景技术通过大规模研究鉴定APLNR(阿糖素受体)的变体RS9943582,与日本人群中缺血性卒中的风险增加相关。我们进行了这项研究,探讨了中国人口中缺血性脑卒中的变异和临床结果之间的关系。方法改善多个连接酶检测反应对变体进行基因型。我们将缺血性脑卒中的平均年龄与单向ANOVA进行了比较。进行了KAPLAN-MEIER方法,对数秩检验和COX比例危害回归模型,分析了变体和临床结果(复发和死亡)之间的关联。结果招募了916例缺血性脑卒中患者进行研究。对于缺血性卒中的年龄,在任何遗传模型中没有鉴定有重大关联。此外,该变体与缺血性卒中的复发和死亡风险不相关,如结果所示。结论研究结果表明,变异RS9943582与缺血性卒中的发病和临床结果无关。然而,来自较大和不同种族群体的精心设计的研究的证据是有必要进一步探索APLNR对缺血性卒中发病和临床结果的影响。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号